Dipeptidyl peptidase-4 inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass and beige/brown fat but not fluid retention (1160.9)

DPP-4 inhibitors are anti-diabetic drugs that enhance renal Na+ and fluid excretion. We tested whether the DPP-4 inhibitor alogliptin (ALG) ameliorates PPARγ agonists pioglitazone (PGZ)-induced flu...